Haemonetics | HAE - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Avanos Medical USD 46.67M 216.61K 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.1M 3.71M 2025-12
Fresenius EUR 563.24M 0 2025-12
Fresenius Medical Care EUR 270.09M 9.2M 2026-03
Globus Medical USD 135.06M 449K 2025-12
Haemonetics USD 46.83M 82K 2025-12
ICU Medical USD 24.69M 2K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
Masimo USD 52.4M 300K 2026-03
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.65M 231K 2026-03
Neogen USD 217.67M 147K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Plus Therapeutics USD 138.68M 7.07M 2025-12
Quidel USD 67.9M 0 2025-12
ResMed USD 190.83M 44.86M 2026-03
STAAR Surgical USD 49.78M 377K 2026-03
Steris USD 98.07M 72K 2026-03
Stryker USD 382.98M 584K 2026-03
Surmodics USD 14.3M 13.58M 2025-06
Teleflex USD 44.26M 70K 2026-03
Terumo JPY 1.48B 11K 2026-03
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
US Physical Therapy USD 15.12M 81.56K 2025-12
Zimmer Biomet Holdings USD 195.5M 2.68M 2026-03